Regis Healthcare Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Regis HealthcareDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -68.2% zurückgegangen, während in der Branche Healthcare die Gewinne wachsen. Die Umsätze sind gewachsen mit einer durchschnittlichen Rate von 5.4% pro Jahr.

Wichtige Informationen

-68.2%

Wachstumsrate der Gewinne

-68.2%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	2.4%
Wachstumsrate der Einnahmen	5.4%
Eigenkapitalrendite	-320.3%
Netto-Marge	-1.7%
Letzte Ertragsaktualisierung	31 Dec 2023

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

May 02

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Mar 21

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

Feb 28

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Oct 18

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Aug 26

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

Feb 25

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

May 27

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

May 09

Should You Be Excited About Regis Healthcare Limited's (ASX:REG) 23% Return On Equity?

Aug 10

At AU$1.32, Is Regis Healthcare Limited (ASX:REG) Worth Looking At Closely?

Aug 10

Reflecting on Regis Healthcare's (ASX:REG) Share Price Returns Over The Last Five Years

Jul 14

Is Regis Healthcare Limited (ASX:REG) An Attractive Dividend Stock?

Jul 02

Aufschlüsselung der Einnahmen und Ausgaben

Wie Regis Healthcare Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

ASX:REG Einnahmen, Ausgaben und Erträge (AUD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
31 Dec 23	880	-15	93
30 Sep 23	830	-22	88
30 Jun 23	781	-28	83
31 Mar 23	761	-45	73
31 Dec 22	741	-61	66
30 Sep 22	733	-50	66
30 Jun 22	725	-39	66
31 Mar 22	719	-16	66
31 Dec 21	713	8	67
30 Sep 21	707	14	65
30 Jun 21	701	20	63
31 Mar 21	700	8	62
31 Dec 20	699	-4	61
30 Sep 20	688	-2	60
30 Jun 20	678	-1	60
31 Mar 20	655	21	58
31 Dec 19	661	39	55
30 Sep 19	654	45	54
30 Jun 19	647	51	54
31 Mar 19	632	51	50
31 Dec 18	617	50	47
30 Sep 18	606	52	46
30 Jun 18	594	54	46
31 Mar 18	586	56	46
31 Dec 17	577	57	47
30 Sep 17	571	59	45
30 Jun 17	565	61	43
31 Mar 17	547	55	40
31 Dec 16	529	50	38
30 Sep 16	505	48	36
30 Jun 16	481	47	34
31 Mar 16	468	59	35
31 Dec 15	455	71	35
30 Sep 15	446	64	35
30 Jun 15	438	58	35
31 Mar 15	433	28	43
31 Dec 14	428	-1	51
30 Sep 14	419	0	52
30 Jun 14	410	1	54
30 Jun 13	354	17	47

Qualität der Erträge: REG ist derzeit unrentabel.

Wachsende Gewinnspanne: REG ist derzeit unrentabel.

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: REG ist unrentabel, und die Verluste haben in den letzten 5 Jahren mit einer Rate von 68.2% pro Jahr zugenommen.

Beschleunigtes Wachstum: Das Gewinnwachstum des letzten Jahres kann nicht mit dem 5-Jahres-Durchschnitt von REG verglichen werden, da das Unternehmen derzeit nicht profitabel ist.

Erträge im Vergleich zur Industrie: REG ist unrentabel, was einen Vergleich des Gewinnwachstums des letzten Jahres mit der Branche Healthcare (-19.1%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: REG hat eine negative Eigenkapitalrendite (-320.26%), da es derzeit unrentabel ist.

Regis Healthcare Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Regis Healthcare Limited to Report First Half, 2024 Results on Feb 26, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

First half 2023 earnings released: AU$0.086 loss per share (vs AU$0.012 loss in 1H 2022)

Regis Healthcare Limited to Report First Half, 2023 Results on Feb 24, 2023

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Recent updates

Price target increased by 8.5% to AU$4.37

Non-Executive Director recently sold AU$68m worth of stock

Is There An Opportunity With Regis Healthcare Limited's (ASX:REG) 38% Undervaluation?

At AU$3.94, Is It Time To Put Regis Healthcare Limited (ASX:REG) On Your Watch List?

Upcoming dividend of AU$0.063 per share

Regis Healthcare (ASX:REG) Has Announced A Dividend Of A$0.0628

First half dividend increased to AU$0.063

Price target increased by 7.3% to AU$3.77

Price target increased by 9.0% to AU$3.52

Price target increased by 7.4% to AU$3.43

Regis Healthcare Limited to Report First Half, 2024 Results on Feb 26, 2024

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited Announces Appointment of Jodie Leonard as Independent Non-Executive Director and to Chair the People and Remuneration Committee

Regis Healthcare Limited (ASX:REG) agreed to acquire Cpsm Pty Ltd for AUD 74.2 million.

Price target increased by 11% to AU$3.07

Price target increased by 7.0% to AU$2.77

Consensus EPS estimates upgraded to AU$0.083 loss

Price target increased by 8.7% to AU$2.74

Regis Healthcare Limited's (ASX:REG) CEO Compensation Looks Acceptable To Us And Here's Why

Price target increased by 8.8% to AU$2.59

Upcoming dividend of AU$0.075 per share at 3.8% yield

Regis Healthcare (ASX:REG) Is Paying Out A Larger Dividend Than Last Year

Consensus EPS estimates fall by 14%, revenue upgraded

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Dividend for the Six Months Ended June 30, 2023, Payable on September 27, 2023

Regis Healthcare Limited Announces the Resignation of Rebecca Dean as Company Secretary

Regis Healthcare Limited, Annual General Meeting, Oct 24, 2023

Regis Healthcare Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

Price target increased by 7.6% to AU$2.33

Consensus EPS estimates fall by 18%

Upcoming dividend of AU$0.02 per share at 3.7% yield

Regis Healthcare (ASX:REG) Is Paying Out Less In Dividends Than Last Year

First half 2023 earnings released: AU$0.086 loss per share (vs AU$0.012 loss in 1H 2022)

Regis Healthcare Limited to Report First Half, 2023 Results on Feb 24, 2023

Consensus forecasts updated

Is Regis Healthcare (ASX:REG) Using Debt Sensibly?

Upcoming dividend of AU$0.023 per share

Regis Healthcare's (ASX:REG) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Announces Fiscal Year 2022 Final Dividend, Payable on September 30, 2022

Regis Healthcare Limited, Annual General Meeting, Oct 25, 2022

Consensus forecasts updated

Consensus forecasts updated

Regis Healthcare Limited to Report Fiscal Year 2022 Results on Aug 24, 2022

Now 21% undervalued

Consensus forecasts updated

Upcoming dividend of AU$0.035 per share

Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Regis Healthcare Limited Declares Franked Ordinary Dividend for the Six Months Ended December 31, 2021, Payable on April 8, 2022

Upcoming dividend of AU$0.046 per share

Full year 2021 earnings released

Price target increased to AU$2.49

Consensus forecasts updated

Insufficient new directors

Is Regis Healthcare Limited (ASX:REG) Potentially Undervalued?

Price target increased to AU$2.22

Estimating The Fair Value Of Regis Healthcare Limited (ASX:REG)

Regis Healthcare Limited to Report Fiscal Year 2021 Results on Aug 31, 2021

Regis Healthcare Limited, Annual General Meeting, Oct 26, 2021

Regis Healthcare Limited to Report First Half, 2021 Results on Feb 24, 2021

Washington H. Soul Pattinson and Company Limited and Ashburn Pty Limited cancelled the acquisition of the remaining 72.76% stake in Regis Healthcare Limited (ASX:REG) from Bryan Dorman and others.

Regis Healthcare Limited Declares No Dividend for the Year 2020

New 90-day low: AU$0.98

Regis Healthcare Limited(ASX:REG) dropped from S&P/ASX Small Ordinaries Index

New 90-day low: AU$1.14

Analysts update estimates

Analysts update estimates

New 90-day low - AU$1.25